The list of drugs that have grabbed headlines for dizzyingly high prices are just the tip of the iceberg. Pharmaceutical companies’ habit of pushing the limits on drug prices is costing states like California billions and driving up the cost of healthcare.
Enough is enough. It’s time for solutions.
California Takes On Out-of-Control Prescription Drug Pricing
SB 17 BRINGS PHARMA’S PRICING TACTICS OUT OF THE SHADOWS
The pharmaceutical industry spent years stalling transparency legislation in the state legislature but, California families made progress in 2017 with the passage of SB 17. There’s more to be done, but this landmark law is paving the way for more sustainable, affordable prescription drug prices.
AB 824 SEEKS TO END PHARMA’S ANTI-COMPETITIVE PRICING TACTICS